ChromaDex Business Blooms After Pulling Niagen Claims Under NAD Review
Executive Summary
Since Council of Better Business Bureaus investigators in May 2018 asked about claims for Tru Niagen, ChromaDex pulled the ads while reaching milestones in product distribution and ingredient licensing.
You may also be interested in...
ChromaDex Pulls Challenged Tru Niagen Ad Claims
After NAD attorneys asked for substantiation, ChromaDex “provided evidence supporting such claims which were not challenged” and stated it discontinued a challenged claim and testimonial.
HBW Market News: FTC Ends Another Supplement Scam, Australia Win For ChromaDex, GOED Report, Herbalife
Herbalife opens 9,200 square-foot training facility in China; GOED's latest annual market report, covering 2017-2018, is available; ChromaDex has two-tear exclusivity for nicotinamide riboside chloride in Australia; and A.S. Research arthritis claims for Synovia end in FTC settlement.
Anti-Aging Supplement Moves Step Closer To EU Launch With EFSA Approval
ChromaDex' dietary supplement Niagen, marketed to help US consumers "age better", has taken a step closer to EU launch with a positive opinion by the European Food Safety Authority.